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Background: Several steps of eukaryotic 
coenzyme Q biosynthesis are still in question. 
Results: Yeast coq null mutants over-expressing 
the Coq8 kinase have stable Coq polypeptides and 
accumulate new Q-intermediates that help 
diagnose the blocked step. 
Conclusion: New functions for Coq polypeptides 
are proposed. 
Significance: Identification of the blocked step 
allows for the use of alternate ring precursors that 
rescue Q biosynthesis in some mutants.  
 
SUMMARY 
Most of the Coq proteins involved in 
coenzyme Q (ubiquinone or Q) biosynthesis are 
interdependent within a multi-protein complex 
in the yeast Saccharomyces cerevisiae. Lack of 
only one Coq polypeptide, as in ∆coq strains, 
results in the degradation of several Coq 
proteins. Consequently, ∆coq strains 
accumulate the same early intermediate of the 
Q6 biosynthetic pathway; this intermediate is 
therefore not informative about the deficient 
biosynthetic step in a particular ∆coq strain. In 
this work, we report that the over-expression of 
the protein Coq8 in ∆coq strains restores steady 
state levels of the unstable Coq proteins. Coq8 
has been proposed to be a kinase and we 
provide evidence that the kinase activity is 
essential for the stabilizing effect of Coq8 in the 
∆coq strains.  This stabilisation results in the 
accumulation of several novel Q6 biosynthetic 
intermediates. These Q-intermediates identify 
chemical steps impaired in cells lacking Coq4 
and Coq9 polypeptides, for which no function 
has been established to date. Several of the new 
intermediates contain a C4-amine and provide 
information on the deamination reaction that 
takes place when para-aminobenzoic acid is 
used as a ring precursor of Q6. Finally, we used 
synthetic analogues of 4-hydroxybenzoic acid to 
bypass deficient biosynthetic steps and we show 
here that 2,4-dihydroxybenzoic acid is able to 
restore Q6 biosynthesis and respiratory growth 
in a ∆coq7 strain over-expressing Coq8. The 
over-expression of Coq8 and the use of 4-
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hydroxybenzoic acid analogues represent 




Coenzyme Q (ubiquinone or Q)7 is a 
redox-active lipid essential for electron and proton 
transport in the mitochondrial respiratory chain. Q 
is also important in the mitochondrial inner 
membrane because it serves as an antioxidant, it 
modulates the function of the mitochondrial 
membrane transition pore and is a cofactor of 
uncoupling proteins (1). Q is composed of a fully-
substituted benzoquinone ring which is attached to 
a polyisoprenyl tail of various length (six 
isoprenyl units in Saccharomyces cerevisiae hence 
Q6, ten units in humans, hence Q10). The 
eukaryotic Q biosynthetic pathway has been 
studied most thoroughly in S. cerevisiae where it 
implicates at least eleven proteins, Coq1-Coq9, 
Arh1, and Yah1 (2,3).  
Genetic and biochemical studies have 
shown that most Coq proteins are present in a high 
molecular mass, multi-subunit Q6 biosynthetic 
complex in S. cerevisiae (4,5). The absence of a 
single Coq polypeptide from the complex causes a 
drastic diminution of the steady state levels of 
some Coq proteins. For example, the steady state 
levels of Coq4, Coq6, Coq7 and Coq9 are 
decreased in each of the ∆coq1- ∆coq9 null strains 
(6). As a result, the same early intermediate 3-
hexaprenyl-4-hydroxybenzoic acid (HHB; Fig. 1, 
path 1), accumulates in each of the ∆coq3-∆coq9 
strains. Certain point mutations resulting in amino 
acid substitutions seem to have less impact on the 
integrity of the Q biosynthetic complex than a null 
mutation; expression of the inactive Coq7-E194K 
polypeptide in a  ∆coq7 strain caused 
accumulation of the expected intermediate 
demethoxy-Q6 (DMQ6, Fig. 1) (7,8). Apart from 
this example, the absence of accumulation of 
biosynthetic intermediates downstream of HHB in 
∆coq strains has hindered our understanding of the 
Q biosynthetic pathway. Therefore the precise 
order of certain biosynthetic steps is still elusive 
and the function of Coq4 and Coq9 is not defined.  
The yeast COQ8 gene was formerly called 
ABC1 and was thought to be essential for complex 
III function (9,10). However, it was later shown 
that COQ8 was required for Q6 biosynthesis and, 
as such, its deletion only affected complex III 
activity indirectly (11). Coq8 is a matrix protein 
peripherally associated with the mitochondrial 
inner membrane (12) and belongs to the “atypical 
kinases” subgroup of the protein-kinase-like 
superfamily (13). Mutations in ADCK3, the human 
ortholog of COQ8, were shown to cause Q10 
deficiency and cerebellar ataxia (13,14). In yeast, 
Coq8 is essential for phosphorylation of Coq3 and 
for its association with the Q biosynthetic complex 
(12,15). In addition, several phosphorylated forms 
of Coq5 and Coq7 disappear in a yeast strain 
expressing the G130D mutant form of Coq8 (12), 
which mimics the pathogenic G272D mutation 
found in ADCK3 (14). Therefore Coq8 appears to 
be a kinase essential for the phosphorylation of 
several conserved Coq polypeptides and some of 
these phosphorylated forms likely play a role in 
the assembly or maintenance of the Q6 
biosynthetic complex. Recent studies indicate that 
over-expression of COQ8 can have profound 
effects on Q6 biosynthesis. Indeed, the over-
expression of Coq8 (from now on referred to as 
Coq8 OE) in a ∆coq7 strain promoted the 
accumulation of DMQ6 (16), implying that all Coq 
proteins acting upstream of Coq7 in the 
biosynthetic pathway were stable and active. The 
effect of Coq8 OE is likely post-transcriptional 
since COQ4 mRNA levels in the ∆coq7 strain 
were not dependent on the level of Coq8 OE (16). 
Recently, the low steady-state level of Coq4 
encountered in ∆coq2, ∆coq3, ∆coq5, and ∆coq7 
strains was shown to be restored to wild-type 
levels by Coq8 OE (17). In the case of a ∆coq6 
strain, Coq8 OE allowed the specific accumulation 
of 3-hexaprenyl-4-hydroxyphenol (4-HP; Fig. 1) 
which led us to identify Coq6 as the 
monooxygenase responsible for the C5-
hydroxylation step (18). This example 
demonstrates that the accumulation of Q6 
biosynthetic intermediates in ∆coq strains and the 
identification of their chemical structure are 
important for understanding the function of Coq 
proteins.  
In addition to the classic Q biosynthetic 
pathway emanating from 4-hydroxybenzoic acid 
(4-HB), S. cerevisiae also makes use of para-
aminobenzoic acid (pABA) as a ring precursor for 
Q6 biosynthesis (Fig. 1, path 2) (3,19). Coq2 is 
able to catalyze the prenylation of 4-HB to yield 3-
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hexaprenyl-4-hydroxybenzoic acid (HHB), as well 
as the prenylation of pABA to yield 3-hexaprenyl-
4-aminobenzoic acid (HAB).  We have 
hypothesized that Coq3-Coq9 enzymes modify 
both HAB and HHB, and that the C4-amino group 
must be removed from the HAB derived 
intermediates in order to produce Q6 (3,19). The 
deamination reaction likely occurs before the C6-
hydroxylation step catalyzed by Coq7 because 4-
imino-DMQ6 (IDMQ6) was proposed to be a 
precursor of DMQ6 (19). Other ring precursors 
than 4-HB and pABA can also be used in vivo by 
S. cerevisiae to synthesize Q6. Indeed, 3,4-
dihydroxybenzoic acid and vanillic acid bypass a 
deficiency in the Coq6-mediated C5-hydroxylation 
reaction and restore Q6 biosynthesis in coq6 or 
yah1 mutant strains (18).  
In this study, we show that Coq8 OE 
restores the steady state levels of the Coq proteins 
in most ∆coq strains. The stabilization of the Coq 
polypeptides leads to the accumulation of Q6 
biosynthetic intermediates which allow the 
diagnosis of the impaired step. We have used this 
property to demonstrate that several biosynthetic 
steps are impaired in the ∆coq4 and ∆coq9 strains 
and to gain insights into the deamination reaction. 
Finally, the use of alternate ring precursors 
promoted the restoration of Q6 biosynthesis and 
respiratory growth for a ∆coq7 strain.  
 
EXPERIMENTAL PROCEDURES 
Yeast Strains and Culture Conditions – S. 
cerevisiae strains used in this study are listed in 
Table 1. S. cerevisiae strains were transformed 
with lithium acetate as described (20,21). YNB 
without pABA and folate (–pABA –folate) was 
purchased from MP Biomedicals. Rich YP 
medium was prepared as described (22). Dextrose 
or lactate-glycerol was used at 2%. In preparation 
for analyses by HPLC-ECD, yeast cells were 
cultured as described (3) and grown for 18 h at 
30°C. Stock solutions of 4-HB analogues at 100 
mM were prepared by slowly titrating NaOH (care 
was taken not to exceed pH 9) until complete 
dissolution. The solutions were then filter-
sterilized and aliquots were kept at –20°C for 
several months. The 4-HB analogues were added 
to –pABA –folate growth medium at the indicated 
concentrations. Alternatively, in preparation for 
analyses by HPLC-MS/MS, yeast cells were 
cultured in Drop Out Galactose medium 
(DOGAL) (19) and labelled as described. Briefly, 
100 OD600 cells were collected from overnight 
culture and transferred to fresh medium in the 
presence of various aromatic ring precursors for 2-
4 hours at 30 oC.  Cells were then collected by 
centrifugation and subject to LC/MS/MS analysis.  
Plasmids – Plasmids used in this study are 
listed in Table 2. COQ7 ORF with its own 
promoter and terminator was cloned into pRS425 
using HindIII and XhoI. Sequencing was used to 
confirm cloning products.  
SDS-PAGE and Immunoblot analysis – 
Whole cell lysate and isolation of mitochondria 
were performed as described (12). Proteins were 
transferred from SDS-polyacrylamide gels to 
polyvinylidene difuloride (PVDF) membrane and 
then incubated with primary antibodies at the 
following dilutions: Coq1, 1:10,000; Coq3, 
1:1000; Coq4, 1:1000; Coq5, 1:10,000; Coq6, 
1:200; Coq7, 1:1000; Coq8, 1:100; and Coq9, 
1:1000 and Pda1 1:1000 ; oat anti-rabbit IgG 
secondary antibodies (Calbiochem) were used at 
1:10,000. 
Lipid Extraction and Detection of 
Electroactive Compounds by HPLC-ECD – 
Cellular lipid extraction after addition of the Q4 
standard and detection of electroactive compounds 
by HPLC-ECD with a 5011A analytical cell (E1, –
550 mV; E2, +550 mV) were conducted as 
described (3). Hydroquinones present in samples 
were oxidized with a precolumn 5020 guard cell 
set in oxidizing mode (E, +650 mV). 
Lipid Extraction and RP-HPLC-MS/MS – 
Lipid extractions of cells made use of Q4 as 
internal standard and all LC-MS/MS analysis were 
performed as previously described (19). Briefly, a 
4000 QTRAP linear MS/MS spectrometer from 
Applied Biosystems (Foster City, CA) was used. 
Applied Biosystem software, Analyst version 
1.4.2, was used for data acquisition and 
processing. A binary HPLC solvent delivery 
system was used with a phenyl-hexyl column 
(Luna 5u, 100 x 4.60 mm, 5 micron, Phenomenex) 
for yeast extracts. The mobile phase consisted of 
Solvent A (methanol:isopropanol, 95:5, with 2.5 
mM ammonium formate) and Solvent B 
(isopropanol, 2.5 mM ammonium formate). The 
percentage of Solvent B was increased linearly 
from 0% to 5% over 6 min, and the flow rate was 
increased from 600 µl/min to 800 µl/min. The 
flow rate and mobile phase were changed back to 
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initial condition linearly by 7 min. All samples 
were analyzed in multiple reaction monitoring 
mode (MRM). 
Purification of Q biosynthetic 
intermediates and high resolution mass 
spectrometry measurements – The compounds 
were purified from yeast cells as previously 
described (3). Samples in methanol were diluted 
with 90% acetonitrile and 0.2% formic acid and 
were infused into the nanospray source of a 
discovery ORBITRAP instrument (Thermo 
Fischer Scientific) at a flow rate of 0.5 µl/min for 
high-resolution mass spectrometry analyses (3).  
 
RESULTS  
Over-expression of Coq8 restores steady 
state levels of Coq proteins in mitochondria of 
∆coq strains— Immunodetection on whole cell 
lysates revealed that Coq4, Coq7, and Coq9 steady 
state levels were increased by Coq8 OE in ∆coq3 
and ∆coq5 strains (Fig. 2A-B). Similarly, Coq8 
OE increased steady state levels of Coq9 and Coq7 
in the ∆coq4 strain, and Coq9 and Coq4 in the 
∆coq7 strain (Fig. 2A). Even though Coq8 OE 
resulted in comparable levels of Coq8 in all ∆coq 
strains tested, it failed to increase the steady-state 
levels of Coq7 and Coq9 in ∆coq1 and ∆coq2 (Fig. 
2B). The inefficiency of Coq8 OE in these two 
strains likely results from the absence of synthesis 
of prenylated Q6-intermediates which have been 
hypothesized  to be important for the stability of 
Coq4 and Coq6 (23). In the ∆coq9 strain, Coq8 
OE did not restore the steady-state levels of either 
Coq4 or Coq7 (Fig. 2A).  
 
Since the yeast Coq polypeptides localize 
to mitochondria (2), we verified that the proteins 
stabilized by Coq8 OE were present in this 
organelle. The Coq4, Coq7 and Coq9 proteins 
were readily detected in mitochondria prepared 
from ∆coq5 and ∆coq6 cells with Coq8 OE (Fig. 
3A). Although previous studies indicated that the 
Coq3 polypeptide was labile in ∆coq strains (6), 
subsequent experiments performed in the presence 
of both protease and phosphatase inhibitors 
preserved steady-state levels of Coq3 (12,15). In 
agreement, Coq3 levels were unaffected in ∆coq5 
or ∆coq6 cells (Fig. 3A).  The Coq6 antibody 
reacts with many nonspecific polypeptides in yeast 
cell extracts and therefore immunoblotting for 
Coq6 is best carried out on isolated mitochondria. 
The steady state level of Coq6 was also increased 
by Coq8 OE in ∆coq3, ∆coq4, and ∆coq7 although 
it did not reach wild-type level (Fig. 3B). Steady 
state levels of the Coq1 polypeptide provide a 
loading control, since Coq1 is unaffected by null 
mutations in ∆coq2-∆coq9 (6).  
Moderate over-expression of kinase-active 
Coq8 is sufficient for the stabilization of Coq 
polypeptides— The yeast W222 mutant (24) has a 
mutated COQ8 gene which encodes a Coq8-
G130D polypeptide that mimics the human 
G272D pathogenic mutation found in ADCK3 
(14). W222 does not synthesize Q6, has low levels 
of Coq4, Coq7 and Coq9 and has no detectable 
phosphorylated form of Coq3, suggesting that the 
G130D mutation completely abolishes the kinase 
activity of Coq8 (12). We tested the importance of 
the kinase activity of Coq8 for the stabilisation of 
Coq proteins in ∆coq strains by over-expressing 
Coq8-G130D. The levels of Coq7 and Coq9 were 
restored in ∆coq6 cells with Coq8 OE but 
remained undetectable with Coq8-G130D OE 
(Fig. 4). Similarly, Coq9 steady state levels were 
restored in ∆coq7 cells with Coq8 OE but not with 
Coq8-G130D OE. Coq8-G130D steady-state level 
was lower than that of wild-type Coq8 over-
expressed from the same high copy vector (Fig. 4). 
Transformation of ∆coq6 and ∆coq7 cells with a 
centromeric plasmid containing the COQ8 gene 
(lcCoq8) resulted in moderate expression of Coq8 
which was sufficient to restore steady-state levels 
of the Coq7 and Coq9 polypeptides (Fig. 4). Since 
the Coq8-G130D polypeptide also accumulates to 
a moderate level upon over-expression, we 
conclude that the kinase activity of Coq8 is 
necessary to cause the stabilization of the Coq 
polypeptides.  
Over-expression of Coq8 promotes the 
accumulation of diagnostic intermediates in ∆coq5 
and ∆coq7 strains—Based on our observation that 
Coq8 OE stabilizes most Coq proteins in the 
collection of the ∆coq strains, we reasoned that 
these mutants may now accumulate Q6 
biosynthetic intermediates downstream of HHB. In 
fact, it has been shown that a ∆coq7 strain known 
to accumulate HHB, can be induced to proceed 
further and to accumulate DMQ6 upon Coq8 OE 
(16). In the present study, we have used HPLC 
separation coupled to either electrochemical 
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detection (ECD) or mass spectrometry (MS) to 
detect Q6 intermediates in lipid extracts of the 
different strains tested. In our HPLC-ECD system, 
a precolumn electrode oxidizes the reduced 
hydroquinone intermediates present in the lipid 
extracts into their oxidized quinone form, 
accounting for the presence of only oxidized 
products in the HPLC-column eluate. In the 
HPLC-MS/MS detection, the redox state of the 
intermediates is detected and affects the elution 
position. Multiple reaction monitoring (MRM) 
allows the detection of the molecular ion of Q6 
intermediates in conjunction with the 
corresponding product ion base peak. A ∆coq7 
strain with Coq8 OE revealed that DMQ6 was 
produced in a synthetic medium supplemented 
with either pABA or 4-HB whereas no 
electroactive compound was detected in the 
absence of Coq8 OE (Fig. 5A and data not 
shown). The synthesis of DMQ6 from pABA is 
consistent with our previous observations that 
DMQ6, but not its imino-counterpart IDMQ6, was 
the main intermediate synthesized when strains 
expressing either a partially inactive form of Coq7 
(3) or a coq7 point mutant (19) were grown in 
pABA containing medium. 
An electro-active compound that eluted 
earlier than DMQ6 was accumulated in a ∆coq5 
strain only upon Coq8 OE (Fig. 5B). The observed 
mass of the purified compound (M+H+) m/z 
547.4150 corresponds to that of demethyl-
demethoxyubiquinone (DDMQ6) ([M+H]+ = 
C37H55O3+: 547.4151; –0.2 ppm), the expected 
substrate of Coq5. The identification of DDMQ6 is 
further supported by the trap scan spectrum which 
showed a tropylium-like ion at m/z 153 
characteristic of Q6-related compounds (Fig. S1A). 
DDMQ6 was synthesized by the ∆coq5 strain with 
Coq8 OE when either 4-HB or pABA were used 
as ring-precursors (Fig. 5B). This result was 
further confirmed by detecting 13C6-DDMQ6 in 
∆coq5 with Coq8 OE grown either in the presence 
of 13C6-pABA or 13C6-4-HB (Fig. 5C, Fig. S1B). 
As expected, no Q6 biosynthetic intermediates 
besides HHB or HAB were detected in either 
∆coq5 or ∆coq7 strains with Coq8-G130D OE 
(data not shown). Our results show that Coq8 OE 
in ∆coq5 and ∆coq7 strains leads to the 
biosynthesis of the expected Q6 intermediates, 
DDMQ6 and DMQ6 respectively.  
Bypass of the Q biosynthetic deficiency in 
∆coq7 cells by 4-HB analogue—Based on our 
recent demonstration of the bypass of the deficient 
C5-hydroxylation reaction in a ∆coq6 strain by 
3,4-dihydroxybenzoic acid (3,4-diHB) and vanillic 
acid (VA) (Fig. 1) (18), we grew ∆coq7 cells with 
Coq8 OE in the presence of 2,4-dihydroxybenzoic 
acid (2,4-diHB). In the presence of 2,4-diHB, cells 
contained a significant amount of Q6 whereas 
growth in the presence of 4-HB only produced 
DMQ6 (Fig. 6A). The product eluting at 780 sec in 
2,4-diHB treated cells is not  DMQ6 since its UV-
vis spectrum has a maximum at 265 nm different 
from that of DMQ6 at 271nm (data not shown). 
Q6-deficient strains have a growth defect on 
respiratory carbon sources because the 
mitochondrial electron transport chain is 
interrupted. The quantity of Q6 synthesized in the 
presence of 2,4-diHB was sufficient to allow 
respiratory growth on lactate-glycerol (Fig. 6B). 
DMQ6 was incompetent at re-establishing the flow 
of electrons in the respiratory chain as shown by 
the absence of growth on respiratory medium 
containing 4-HB (Fig. 6B). Likewise, Coq8-
G130D OE failed to rescue the respiratory growth 
defect of the ∆coq7 strain in the presence of 2,4-
diHB. These results show that it is possible to 
bypass the deficient C6-hydroxylation reaction in 
a ∆coq7 strain with 2,4-diHB provided that Coq 
polypeptides are stabilized by Coq8 OE.  
Yeast  ∆coq3 and ∆coq4 cells over-
expressing Coq8 accumulate early Q biosynthetic 
intermediates—We detected only HAB and HHB 
in a ∆coq3 strain with Coq8 OE (data not shown). 
This was surprising to us since Coq4, Coq7, Coq9 
(Fig. 2A) and Coq6 (Fig. 3B) are stable in a ∆coq3 
strain with Coq8 OE and we therefore expected 
the accumulation of 3-hexaprenyl-4,5-
dihydroxybenzoic acid (DHHB), the product of 
Coq6. VA bypassed the requirement for the C5-
hydroxylase (Coq6) and the O5-methyltransferase 
(Coq3) and led to the accumulation of DMQ6 in 
the ∆coq3 strain with Coq8 OE (Fig. 7A). This 
result demonstrates that the C1-decarboxylase, the 
C1-hydroxylase and Coq5 are active in the ∆coq3 
strain. 
In a ∆coq4 strain grown in the presence of 
13C6-pABA, Coq8 OE caused the accumulation of 
a product whose mass is consistent with the 13C6 
labelled form of 3-hexaprenyl-4-amino-5-
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hydroxybenzoic acid (HHAB; Fig. 7B). HHAB 
was also detected in the coq4-1 point mutant (Fig. 
7B) and trap scan spectra confirmed both the 
unlabeled and 13C6 labelled forms of HHAB (Fig. 
S2A-B). The HHAB intermediate is not observed 
in pABA-labelled wild-type yeast (data not 
shown). Upon culture with 13C6-4HB, the 
corresponding anticipated intermediate, 13C6-
DHHB was not detected in Coq4-deficient strains, 
only 13C6-HHB was detected (data not shown). We 
also failed to detect DHHB in the ∆coq4 strain 
with Coq8 OE even when the medium was 
supplemented with 3,4-diHB (100 ug/ml; data not 
shown). The accumulation of HHAB suggested a 
deficient O5-methyltransferase activity, even 
though the Coq3 polypeptide is stable in the ∆coq4 
strain. Addition of VA to ∆coq4 strain with Coq8 
OE failed to generate either DMQ6 (Fig. 7A) or 
the predicted prenylation product, 3-hexaprenyl-4-
hydroxy-5-methoxybenzoic acid (data not shown). 
Addition of 3-methoxy-4-aminobenzoic acid 
(AMB) to the growth medium of the coq4-1 point 
mutant, led to the accumulation of 3-hexaprenyl-4-
amino-5-methoxybenzoic acid (HMAB; Fig. 7C 
and Fig. S3). HMAB is expected to accumulate in 
cells deficient for the C1-decarboxylation reaction. 
However, it is important to note that HMAB is 
also observed in wild-type yeast incubated in the 
presence of AMB (Fig. 7C). Therefore, a possible 
defect in the C1-decarboxylation reaction in the 
coq4-1 point mutant can not be probed by using 
AMB. Collectively, our data show that only early 
amino-intermediates of the Q pathway accumulate 
in coq4 yeast mutants and that the use of 
analogues of 4-HB or pABA does not cause the 
accumulation of downstream intermediates 
contrary to what we obtained in ∆coq3 (Fig. 7A) 
or ∆coq7 (Fig. 6A) mutants. Therefore, in addition 
to the O5-methylation which we proved to be 
deficient in a coq4 mutant, at least one other 
downstream biosynthetic step of the Q6 pathway is 
impaired. This situation is consistent with a more 
general functional/structural role for Coq4 in the 
Q6 biosynthetic complex (5).  
Yeast ∆coq9 cells over-expressing Coq8 
accumulate intermediates diagnostic of a 
deficiency in C5 and C6-hydroxylation reactions—
Coq9 is essential for Q6 biosynthesis but its 
molecular function is unknown (25). Upon Coq8 
OE, we observed the accumulation of distinct 
electroactive compounds depending on whether 
pABA or 4-HB was added to the growth medium 
of a ∆coq9 strain (Fig. 8A). In the presence of 4-
HB, two compounds were detected with UV-
visible spectra (not shown) and retention times 
characteristic of DMQ6 and of the oxidized form of 
3-hexaprenyl-4-hydroxyphenol (4-HP). The 
identity of these intermediates was further 
confirmed by labelling with 13C6-4-HB and by 
comparing the lipid extracts of ∆coq9 cells to 
those of ∆coq6 cells which are known to contain 
4-HP (18) (525.4 to 129 transition at 2.66 min, 
Fig. 8B) and to those of ∆coq7 cells that contain 
DMQ6 (567.6 to 173 transition at 4.86 min, Fig. 
8C). In the presence of pABA (Fig. 8A), the 
compound eluting at 600 sec corresponds to the 
oxidized form of 3-hexaprenyl-4-aminophenol (4-
AP). The compound eluting at 860 sec (Fig. 8A) 
was identified as 4-imino-demethoxyquinone 
(IDMQ6) based on its observed mass (M+H+) m/z 
560.44458 (IDMQ6; [M+H]+ = C38H58NO2+: 
560.44675; –3.90 ppm) and its fragmentation 
spectrum with tropylium-like and chromenylium-
like ions at m/z 166 and 206 (Fig. S4A) which are 
shifted with M+6 (m/z) upon labelling with 13C6-
pABA (Fig. S4B). The 13C6-labeled form of 4-AP 
(524.4 to 128 transition at 2.86 min, Fig. 8D; trap 
scan spectra Fig. S5) was detected in ∆coq6 and 
∆coq9 cells and 13C6-IDMQ6 (566.6 to 172 
transition at 4.76 min, Fig. 8E) was present in 
∆coq7 and ∆coq9 cells.  The ion with a 525.4 to 
129 transition at 2.86 min in ∆coq6 cells with 
Coq8 OE (Fig. 8B) is attributed to the +1 isotope 
of 13C6-4-AP (compare Figs. 8B and 8D). 
Likewise, the signal at 4.76 min (Fig. 8C) actually 
corresponds to the +1 isotope of 13C6-IDMQ6 
(566.6 to 172 transition; compare Figs. 8C and 
8E). Our experiments show that ∆coq9 cells with 
Coq8 OE accumulate 4-AP / 4-HP which are 
diagnostic of a deficiency in the C5-hydroxylation 
catalyzed by Coq6 (18) and DMQ6 / IDMQ6 which 
are formed consequently to a defect in the C6-
hydroxylation reaction catalyzed Coq7. Moreover, 
the C4-deamination (black dotted arrows in Fig. 1) 
of Q6 biosynthetic intermediates originating from 
pABA is not efficiently catalyzed in the absence of 
Coq9. In conclusion, deletion of coq9 impacts on 
the activity of multiple Coq proteins: Coq6, Coq7 
and the putative deaminase.  
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We next attempted to bypass the 
biosynthetic defects of ∆coq9 cells. 
Supplementation of the growth medium with VA 
caused the accumulation of DMQ6 (Fig. S6), 
showing that even though the Coq6 deficiency 
could be bypassed, a strong block subsists at the 
level of Coq7. With 2,4-diOH, no Q6 could be 
detected but instead a new electroactive compound 
at 730 sec appeared (Fig. S6). The absence of Q6 
biosynthesis may be caused by the poor stability of 
several Coq polypeptides even with Coq8 OE (Fig. 
2A). Indeed, the quantity of intermediates 
accumulated in the ∆coq9 strain is lower than that 
obtained in ∆coq6 and ∆coq7 strains (Fig. 8B-D) 
which have higher levels of Coq polypeptides 
compared to the ∆coq9 strain (Fig. 2A). Finally, 
2,3,4-trihydroxybenzoic acid which could in 
theory bypass both C5 and C6-hydroxylations was 
found to inhibit Q6 biosynthesis in WT cells and 
was therefore not tested further (data not shown).  
 
DISCUSSION 
Most of the Coq polypeptides involved in Q6 
biosynthesis in S. cerevisiae are part of a 
multiprotein complex. Among Coq proteins, only 
Coq2 is predicted to possess transmembrane 
domains. Organization of the Coq polypeptides in 
a Q6 biosynthetic complex associated with the 
mitochondrial inner membrane helps rationalize 
how these proteins can gain access to their 
substrates which are hexaprenylated lipophilic 
compounds likely imbedded in the membrane 
(26). In the absence of any one of the Coq 
polypeptides (∆coq1- ∆coq9 strains), assembly of 
the Q6 biosynthetic complex is impaired which 
results in the degradation of Coq4, Coq6, Coq7 
and Coq9. This situation is not unique for multi-
protein complexes in S. cerevisiae and is also 
encountered for example with cytochrome c 
oxidase. Indeed most Cox proteins are degraded in 
the absence of any of the three mitochondrially-
encoded core subunits Cox1-Cox3 (27). Our 
present study establishes that Coq8 OE stabilizes 
the levels of Coq4, Coq6, Coq7 and Coq9 in 
∆coq3-∆coq7 strains and therefore generalizes to 
most Coq polypeptides this stabilizing effect 
which had previously been described for Coq4 
(17).  The stabilized proteins are active since they 
allowed accumulation of novel Q6 biosynthetic 
intermediates in several ∆coq strains, suggesting 
that the Q6 biosynthetic complex is at least 
partially assembled.  
Coq8 has been proposed to possess a 
kinase activity (11) and has been shown to be 
necessary for the existence of phosphorylated 
forms of Coq3, Coq5 and Coq7 in vivo (12,15). A 
G130D mutation in Coq8 abolishes the 
phosphorylated form of Coq3 suggesting that this 
mutation impairs the kinase activity (12). Our data 
with the G130D mutant indicate that the kinase 
activity of Coq8 is also important for the 
stabilization of Coq6 and Coq7 (Fig. 4) and 
probably also of Coq4 and Coq9. How does Coq8 
OE stabilize Coq polypeptides which are 
otherwise degraded? A direct phosphorylation by 
Coq8 of the polypeptides could occur, especially 
in the case of Coq7 for which Coq8-dependent 
phosphorylated forms have been detected (12). 
However, a direct phosphorylation seems unlikely 
in the case of Coq4 since no phosphorylated forms 
of this protein could be detected (12). In addition, 
we do not currently know whether Coq6 and Coq9 
are phosphorylated in vivo (12). So to explain the 
effect of Coq8, we favor a hypothesis in which 
Coq8 OE increases the phosphorylation state of a 
particular Coq protein which modulates the 
assembly and/or stability of the Q6 biosynthetic 
complex. An obvious candidate is Coq3 whose 
association with the Q6 biosynthetic complex was 
shown to be dependent on Coq8 (15). However, 
stable Coq proteins are detected in a ∆coq3 strain 
with Coq8 OE (Fig. 2A), establishing that 
phosphorylated Coq3 is not the only factor 
promoting the stabilization of the Coq 
polypeptides. Coq8-dependent phosphorylation(s) 
may be considered a positive regulator of Q6 
biosynthesis since it seems to favour assembly of 
the Q6 biosynthetic complex which should lead to 
increased Q6 biosynthesis. On the contrary, a 
regulatory phosphorylation with a negative impact 
on Q6 biosynthesis has recently been described for 
Coq7 (28). In that study, an increase in the 
phosphorylated forms of Coq7 correlated with a 
decreased level of Q6 and an increased level of 
DMQ6, the substrate of Coq7. It was therefore 
concluded that phosphorylated Coq7 has 
diminished activity (28).  It remains to be 
established which kinase is responsible for the 
phosphorylation of the regulatory sites of Coq7.  
We exploited the stabilizing effect of 
Coq8 OE to understand more precisely the Q6 
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biosynthetic pathway, especially the role played 
by Coq4 and Coq9. We observed the accumulation 
of several intermediates in strains lacking Coq9 or 
Coq4 contrary to strains lacking Coq5 or Coq7 
which accumulate a single late-stage intermediate, 
the substrate of the missing enzyme. In 
consequence, the impairment of several 
biosynthetic steps in ∆coq9 and ∆coq4 cells points 
to a role of these proteins in the general function 
or organization of the Q6 biosynthetic complex 
rather than to a role in the catalysis of a particular 
biosynthetic step. In ∆coq9 cells with Coq8 OE, 
the accumulation of 4-AP / 4-HP establishes that 
the C5-hydroxylation step catalyzed by Coq6 is 
limiting but this C5-hydroxylation occurs to some 
extent as demonstrated by the accumulation of 
IDMQ6 / DMQ6. These later intermediates reveal 
that the C6-hydroxylation catalyzed by Coq7 is 
also deficient. In fact,
 
the C6-hydroxylation is 
completely impaired because addition of VA 
which bypasses the C5-hydroxylation resulted in 
increased accumulation of DMQ6 without any 
production of detectable Q6 or demethyl-Q6 (Fig. 
S6). The role of Coq9 in the C5- and C6-
hydroxylation reactions is not clear but Coq9 
appears to be important for the stability of Coq7 
because steady-state levels of Coq7 are not 
restored in ∆coq9 cells with Coq8 OE. 
Nevertheless, Coq9 is not absolutely required for 
the stability of the Q6 complex to which it has 
been shown to belong (6), because the 
accumulation of DMQ6 implies that the Coq 
enzymes implicated in the Q6 pathway upstream of 
Coq7 are stable and active, at least partially.  
The ∆coq4 strain was diagnosed to be 
impaired in multiple biosynthetic steps: Coq3, 
which catalyses both the O5- and O6-methylation 
steps, does not function in the ∆coq4 strain as 
established by the accumulation of HHAB. 
Furthermore, addition of VA did not generate 
DMQ6 in the ∆coq4 strain, contrary to what we 
observed in the ∆coq3 strain (Fig. 7A), revealing 
that at least another biosynthetic step downstream 
of the O5-methylation is impaired. In agreement 
with these results, Coq4 was hypothesized to serve 
as an anchor for the Q6 biosynthetic complex (5) 
and was recently proposed to bind the 
polyisoprenyl tail of Q6-intermediates, therefore 
allowing sequential modification of the aromatic 
head group (29). It is of interest to note that a 
diploid yeast carrying a deletion of one allele of 
COQ4 showed a diminished Q6 content 
demonstrating that wild-type level of Coq4 is 
crucial for the function of the Q6 biosynthetic 
complex (30). Human Coq4 may play an 
analogous role in organizing Q10 biosynthesis 
since COQ4 haploinsufficiency was recently 
shown to cause Q10 deficiency in a patient (30). 
It is interesting that Q6 intermediates 
containing a catechol moiety (DHHB and 
demethyl-Q6) could not be detected in this study 
despite the fact that we expected their synthesis in 
some of the strains tested. Indeed, we anticipated 
the formation of DHHB in a ∆coq4 strain grown in 
the presence of 4-HB because this strain produced 
HHAB from pABA. Also, the ∆coq3 strain 
synthesized DMQ6 but not demethyl-Q6 from VA. 
In consequence, the catechol-containing Q6 
intermediates may be unstable and hence can not 
accumulate in detectable amount in S. cerevisiae.    
pABA is a precursor of Q6 in S. cerevisiae 
and the C4-amine must be replaced by a C4-
hydroxyl along the Q6 pathway (3,19). Our data 
reveal several new elements regarding this C4-
deamination (or deimination) reaction. First, 
∆coq6 and ∆coq9 cells with Coq8 OE synthesized 
C4-aminated intermediates (4-AP and IDMQ6) in 
the presence of pABA; but synthesized the C4-
hydroxylated intermediates (4-HP and DMQ6) in 
the presence of 4-HB. This result supports the 
notion that HHB and HAB follow the same 
biosynthetic steps up to DMQ6 / IDMQ6 and are 
modified by the same Coq enzymes which thus 
accommodate both C4-hydroxylated and C4-
aminated Q6 biosynthetic intermediates (path 1 
and path 2, Fig. 1). Second, the deamination 
reaction does not proceed via non-enzymatic 
hydrolysis because in this case, IDMQ6, which 
was previously established to be a precursor of 
DMQ6, should be converted into DMQ6. Third, the 
C4-deamination/deimination reaction occurs 
efficiently in some mutants (∆coq5 and ∆coq7), 
but not in others (∆coq6, ∆coq9 and possibly 
∆coq4). The deamination reaction may implicate 
Coq6 or Coq9 or an uncharacterized protein which 
may be inactive or unstable in ∆coq6 and ∆coq9 
cells. In this latter case, a differential proteomic 
analysis of ∆coq5 and ∆coq7 cells on the one hand 
and ∆coq6 and ∆coq9 cells on the other hand, may 
reveal the identity of the C4-deaminase. Fourth, 
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the deamination reaction can occur prior to the C2-
methylation catalyzed by Coq5 as supported by 
the accumulation of DDMQ6 and not 2-demethyl-
4-amino-demethoxy-Q6 (IDDMQ6) by the ∆coq5 
strain cultured in the presence of pABA. The step 
at which the deamination reaction occurs in a WT 
strain is still in question. Indeed, it could take 
place prior to the C2-methylation or prior to the 
C6-hydroxylation catalyzed by Coq7 as suggested 
by the results establishing that IDMQ6 is a 
precursor of DMQ6 (19). In that study, the coq7-1 
point mutant and also wild-type yeast grown in the 
presence of pABA, accumulated lower quantities 
of IDMQ6 compared to DMQ6 (19), in agreement 
with results presented in this present study. The 
real question now concerns the reasons of the 
synthesis of the minute amounts of IDMQ6 
detected in WT cells: Is it a “normal” intermediate 
which only accumulates in small quantities 
because it is efficiently converted into DMQ6 or 
does IDMQ6 represent a byproduct formed when 
the deamination reaction that may occur prior to 
Coq5 is rate-limiting? Further experiments will 
address this question. 
The accumulation of Q6 intermediates in 
∆coq4 and ∆coq9 cells with Coq8 OE shed some 
light on the biosynthetic defects in these strains 
and is a significant advance in our understanding 
of Q6 biosynthesis. Furthermore, the use of the 
2,4-diHB aromatic ring precursor together with 
Coq8 OE was shown to restore Q6 biosynthesis in 
yeast ∆coq7 cells. Finally, the accumulation of 
C4-aminated intermediates in some ∆coq strains 
provided new information regarding the 
deamination reaction. Overall, our study describes 
that Coq8 OE and the use of 4-HB analogues 
represent valuable tools to advance our 
comprehension of the Q6 biosynthetic pathway by 
allowing for the unprecedented molecular 
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7The abbreviations used are: 4-AP, 3-hexaprenyl-4-aminophenol; DDMQ6, the oxidized form of 
demethyl-demethoxy-Q6H2; DHHB, 3-hexaprenyl-4,5-dihydroxybenzoic acid; DIDMQ6H2, 2-demethyl-4-
amino-demethoxy-Q6H2; 3,4-diHB, 3,4-dihydroxybenzoic acid; 2,4-diHB, 2,4-dihydroxybenzoic acid; 
DMQ6, demethoxy-Q6; DMQ6H2, demethoxy-Q6H2; ECD, electrochemical detection; 4-HB, 4-
hydroxybenzoic acid; HAB, 3-hexaprenyl-4-aminobenzoic acid; HHAB, 3-hexaprenyl-4-amino-5-
hydroxybenzoic acid; HHB, 3-hexaprenyl-4-hydroxybenzoic acid; HMAB, 3-hexaprenyl-4-amino-5-
methoxybenzoic acid; 4-HP, 3-hexaprenyl-4-hydroxyphenol; IDDMQ6H2, 2-demethyl-4-amino-
demethoxy-Q6H2;   IDMQ6, 4-imino-demethoxy-Q6; MRM, multiple reaction monitoring; OE, over-
expression; pABA, para-aminobenzoic acid; Q, ubiquinone or coenzyme Q; Q6H2, ubiquinol or 
coenzyme Q6H2; RP-HPLC-MS/MS; Reverse phase-high performance liquid chromatography-tandem 
mass spectrometry; VA, vanillic acid (4-hydroxy-3-methoxybenzoic acid).  
FIGURE LEGENDS 
Figure 1. S. cerevisiae Q6 biosynthetic pathway: accumulation of Q6 biosynthetic intermediates caused by 
the over-expression of Coq8 in ∆coq strains. The classic Q biosynthetic pathway is shown in path 1 
emanating from 4-hydroxybenzoic acid (4-HB). Coq1 (not shown) synthesizes the hexaprenyl-
diphosphate tail which is transferred by Coq2 to 4-HB to form 3-hexaprenyl-4-hydroxybenzoic acid 
(HHB).  R represents the hexaprenyl tail present in all intermediates from HHB to Q6. Alternatively, in 
path 2, para-aminobenzoic acid (pABA) is prenylated by Coq2 to form 3-hexaprenyl-4-aminobenzoic 
acid (HAB). Both HHB and HAB are early Q6-intermediates, readily detected in each of the coq null 
strains (∆coq3-∆coq9). The numbering of the aromatic carbon atoms used throughout this study is shown 
on the reduced form of Q6, Q6H2. Coq8 OE in certain ∆coq strains leads to the accumulation of the 
following compounds: 4-AP, 3-hexaprenyl-4-aminophenol; 4-HP, 3-hexaprenyl-4-hydroxyphenol; 
HHAB, 3-hexaprenyl-4-amino-5-hydroxybenzoic acid; HMAB, 3-hexaprenyl-4-amino-5-methoxybenzoic 
acid; DDMQ6H2, the reduced form of demethyl-demethoxy-Q6; IDMQ6, 4-imino-demethoxy-Q6; 
IDMQ6H2, 4-amino-demethoxy-Q6H2; DMQ6, demethoxy-Q6; DMQ6H2, demethoxy-Q6H2. IDDMQ6H2,  
2-demethyl-4-amino-demethoxy-Q6H2 and DHHB, 3-hexaprenyl-4,5-dihydroxybenzoic acid are shown in 
parentheses to indicate that they have not been detected in this study. Black dotted arrows (from path 2 to 
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path 1) designate the replacement of the C4-amine with a C4-hydroxyl and correspond to the C4-
deamination/deimination reaction. A putative mechanism to replace the C4-imino group with the C4-
hydroxy group is shown in blue brackets for IDMQ6 but could also occur on IDDMQ6 (not shown). 4-AP 
and 4-HP which are formed upon inhibition of the C5-hydroxylation catalyzed by Coq6 are shown in red. 
Analogues of 4-HB and pABA allowing the bypass of certain steps in Q biosynthesis are indicated in 
green. Steps defective in the ∆coq9 strain are designated with a red asterisk.  
Figure 2. Over-expression of Coq8 in several ∆coq strains restores steady-state levels of Coq4, Coq7, and 
Coq9. Whole cell lysates were prepared from W303-1B wild-type yeast (WT) or from the indicated ∆coq 
strains (all except ∆coq9 in W303 genetic background) with (+) or without (–) p4HN4, a multi-copy 
plasmid with yeast COQ8 (Coq8). Yeast cells cultured in YPGal medium to mid-log (2-3 OD600nm) were 
harvested and aliquots of 20 OD600nm  were lysed and analyzed by SDS-PAGE (10% acrylamide) followed 
by transfer to PVDF membrane and immunoblotting with antibodies to the designated Coq polypeptides 
or to Pda1, the alpha subunit of pyruvate dehydrogenase. (A) Pda1 serves as a loading control; (B) Coq1 
and/or Coq5 serve as loading controls. 
Figure 3. Over-expression of Coq8 restores steady state levels of Coq polypeptides in isolated 
mitochondria. Isolated mitochondria were purified with Opti-Prep gradients from W303-1B wild-type 
yeast (WT) or from the designated ∆coq strains (W303 genetic background) with (+) or without (–) 
p4HN4 (Coq8). Aliquots of mitochondrial protein (20 µg) were analyzed by SDS-PAGE followed by 
immunoblot analyses with antisera to the designated Coq polypeptides (A) or with antisera to Coq6 (B). 
Coq1 serves as a loading control. 
Figure 4. Over-expression of Coq8-G130D does not restore steady-state levels of Coq polypeptides. 
Whole cell lysates were prepared as described in Figure 2 from W303-1B wild-type yeast (WT) or from 
∆coq6 or ∆coq7 strains (W303 genetic background) harboring either no plasmid; pFL44, a multi-copy 
plasmid expressing Coq8 (hcCoq8); G130D, a multi-copy plasmid with Coq8 containing the G130D-
mutation (G130D); or p3HN4, a low copy plasmid expressing Coq8 (lcCoq8). Yeast cells were cultured 
in SD–Ura medium to mid-log (2-3 OD600nm), harvested and aliquots of 20 OD600nm were lysed and 
subjected to immunoblotting analyses with antisera to the designated Coq polypeptides. Pda1 serves as a 
loading control. 
 
Figure 5. ∆coq7 and ∆coq5 strains over-expressing Coq8 accumulate the respective Q-intermediates, 
DMQ6 and DDMQ6. (A)  ∆coq7 cells (W303 genetic background) transformed with pFL44 an episomal 
vector encoding Coq8 (Coq8) were grown overnight in YNB–pABA –folate 2% dextrose with no 
additions or with 5 µM of 4-HB or pABA. Lipid extracts of 4 mg of cells (no addition) or of 1.5 mg of 
cells (4-HB, pABA) were analyzed by HPLC-ECD. The peaks corresponding to DMQ6 and to the Q4 
standard are marked. (B) ∆coq5 cells (W303 genetic background) transformed either with pFL44 (Coq8) 
or an empty vector (vec) were grown overnight in YNB–pABA –folate 2% dextrose containing either no 
addition or 5 µM of 4-HB or pABA. Lipid extracts of 10 mg of cells were analyzed by HPLC-ECD. (C) 
∆coq5 cells (W303 genetic background) containing either no plasmid or p4HN4, an episomal vector 
encoding Coq8 (Coq8) were first grown in YPGal + 0.1% dextrose and then cultured in DOGAL+0.1% 
dextrose –pABA –folate –tyrosine overnight. Finally cells were collected and transferred to fresh 
DOGAL+0.1% dextrose –pABA –folate in the presence of either 13C6-4HB or 13C6-pABA (10 µg/ml; 3 
ml) and incubated for 2 h. Cells were collected (150 OD600nm) and lipid extracts were subjected to RP-
HPLC-ESI/MS-MS as described in Experimental Procedures and detection of the precursor-to-product 
ion transition (553.4/159.0) was performed with MRM. The traces indicate arbitrary units and the scale is 
the same for all traces within a panel. 
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Figure 6. Bypass of the respiratory growth defect of the ∆coq7 strain with alternate ring precursors. 
(Α) ∆coq7 cells (W303 genetic background) transformed with an episomal vector coding for Coq8 
(pFL44) were grown in YNB–pABA –folate 2% dextrose containing 1 mM 2,4-dihydroxybenzoic acid 
(2,4-diHB) or not (–). Lipid extracts of 2 mg of cells were analyzed by HPLC-ECD. (B)  WT W303 cells 
or ∆coq7 cells transformed either with an empty vector (vec), an episomal vector (pFL44) encoding Coq8 
or Coq8-G130D, or with an episomal vector encoding Coq7 were grown in YNB–pABA –folate 2% 
dextrose for 24 h and serial dilutions were spotted onto agar plates. The plates contained either YP 2% 
dextrose (Glu) or synthetic medium –pABA –folate supplemented with 2% lactate-2% glycerol (LG) 
containing either 4-HB or 2,4-dihydroxybenzoic acid (2,4-diHB) at 1 mM.  The plates were incubated for 
2 days (Glu) or 4 days (LG) at 30 °C. 
 
Figure 7. ∆coq3 and ∆coq4 strains over-expressing Coq8 or a coq4-1 strain accumulate early Q6 
biosynthetic intermediates. (A) Yeast ∆coq3 (BY4741 genetic background) and ∆coq4 cells (BY4742 
genetic background) transformed with pFL44, an episomal vector encoding Coq8 (Coq8) were grown in 
YNB–pABA –folate 2% dextrose containing 100µM vanillic acid (VA) or 100µM 4-HB. Lipid extracts 
of 4 mg of cells were analyzed by HPLC-ECD. (B) Yeast ∆coq4 cells (W303 genetic background) 
transformed with p4HN4, an episomal vector encoding Coq8, and coq4-1 cells were grown in 
YPGal+0.1% dextrose overnight and labelled in DOGAL+0.1% dextrose –folate –pABA in the presence 
of either 13C6-4HB or 13C6-pABA (20 µg/ml; 3 ml) for 2 hours. Lipid extracts of 100 OD600nm of cells 
were analyzed by RP-HPLC-MS/MS as described in Experimental Procedures and detection of the 
precursor-to-product ion transition (568.0/172.0) was performed with MRM. (C) Yeast coq4-1 mutant 
cells or wild-type yeast cells were grown in YPGal+0.1% dextrose overnight and transferred into 3 ml 
fresh DOGAL+0.1% dextrose –folate –pABA in the presence of 100 µg/ml 4-amino-3-methoxybenzoic 
acid (AMB). Lipid extracts of 100 OD600nm of cells were analyzed by RP-HPLC-ESI/MS-MS as described 
in Experimental Procedures and detection of the precursor-to-product ion transition (576.0/180.0) was 
performed with MRM.  
 
Figure 8. Coq9 is important for Coq6 and Coq7 hydroxylation steps and for removal of the amino 
substituent. (A ) ∆coq9 cells (BY4742 genetic background) transformed either with an episomal vector 
coding for Coq8 (pFL44), or an empty vector (vec), were grown in YNB–pABA –folate 2% dextrose 
containing or not 5 µM 4-hydroxybenzoic acid (4-HB) or pABA. Lipid extracts of 10 mg of cells were 
analyzed by HPLC-ECD. The peaks corresponding to demethoxyubiquinone (DMQ6), to imino-
demethoxyubiquinone (IDMQ6), or to the oxidized forms of 3-hexaprenyl-4-aminophenol (4-AP) and of 
3-hexaprenyl-4-hydroxyphenol (4-HP) are marked. (B) – (E) Yeast ∆coq6, ∆coq7, ∆coq9, in the absence 
or presence of p4HN4 (an episomal plasmid encoding Coq8) were cultured and prepared as described in 
Figure 5. Yeast cell pellets (150 OD600nm of cells) were subjected to RP-HPLC-MS/MS as described in 
Experimental Procedures and detection of the designated precursor-to-product ion transitions 
(525.4/129.0, 524.4/128.0, 567.6/173.0, 566.6/172.0) were performed with MRM. 
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Table 1 
Genotype and Source of Yeast Strains 
Strain Genotype Source 
W303-1A 
 
MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 R. Rothsteina 
W303∆coq1 
 



































MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
abc1/coq8::HIS3 
(33) 
BY4741 MAT a his3∆1 leu2∆0 met15∆0 ura3∆0 (37) 
BY4741∆coq9 
 
MAT a coq9∆::kanMX4 his3∆1 leu2∆0 met15∆0 
ura3∆0 
(38)b 
C9-E1 MAT a ade2-1, coq4-1, trp1-1, ura3-1 (39) 
BY4741∆coq3 
 














 Dr. Rodney Rothstein, Department of Human Genetics, Columbia University. 
b
 European Saccharomyces cerevisiae Archive for Functional Analysis (EUROSCARF), available on-
line.  
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Table 2 
Plasmid constructs used in this study 
Plasmid Relevant Genes Copy number Source 
pRS316 Yeast shuttle vector Low copy (40) 
pRS426 Yeast shuttle vector Multi copy (41) 
p3HN4 Yeast ABC1/COQ8 Low copy (11) 
p4HN4 Yeast ABC1/COQ8 Multi copy (42) 
pFL44 Coq8 Yeast ABC1/COQ8 Multi copy (9) 
pFL44 Coq8 G130D Yeast ABC1/COQ8 G130D Multi copy (14) 
pRS425 Coq7 Yeast COQ7 Multi copy This work 
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Figure 8 
 
 
 
 
 
 
 
 
 
